1. Aman, M. G., Buican, B., and Arnold, L. E. (2003). Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. J. Child Adolesc. Psychopharmacol. 13: 29–40.
2. Aman, M. G., Pejeau, C., Osborne, P., Rojahn, J., and Handen, B. (1996). Four-year follow-up of children with low intelligence and ADHD. Res. Dev. Disabil. 17: 417–432.
3. Aman, P. A., Waltonen, S. J., Olson, K. A., Theye, F. W., Ban Erem, A. J., and LaPlant, R. J. (1993). Placebo-controlled evaluation of MPH side effects. Pediatrics 91: 1101–1106.
4. American Psychological Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th edn.), American Psychiatric Association, Washington, DC, pp. 78–85.
5. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., Tucker, E. E., and Cowdry, R. W. (1990). Side-effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics 86: 184–192.